![](https://investorshub.advfn.com/uicon/477123.png?cb=1533675489)
Tuesday, February 07, 2017 4:52:02 PM
I mention Glucophage because it is HUGE... the $1.2 BILLION market reflects sales of all the generics... and IF/WHEN we get approval it can immediately hit the market with Mallinckrodt.
Assuming a 50-50 split with Mallinckrodt... every 1% of the market that IPCI/MNK capture will be $24 million... or $12 million to IPCI's bottom line... assuming 2.5% penetration IPCI's pure profit would be $30 million a year.
I believe Pristiq will be the next approval because the generic field is not yet saturated... and since there are only ~ 6 generic mfgs then if IPCI/MNK captures a mere 5% of that $843 million market that = $42 million or approx. $21 million to IPCI's bottom line.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM